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Abstract 
In the UK, circulatory death (DCD) kidney transplant activity has increased rapidly, but 
marked regional variation persists. We report how increased DCD kidney transplant activity 
influenced wait-listed outcomes for a single centre. Between 2002/03 and 2011/12, 430 
(54%) DCD and 361 (46%) DBD kidney-only transplants were performed in the Cambridge 
Transplant Centre, with a higher proportion of DCD donors fulfilling expanded criteria status 
(41% DCD vs 32% DBD; P=0.01). Compared to UK outcomes, where the proportion of 
DCD:DBD kidney transplants performed is lower (25%; P<0.0001), listed patients at our 
centre waited less time for transplantation (645 vs 1045 days; P<0.0001), with higher 
transplantation rates, and lower numbers of waiting-list deaths. This was most apparent for 
elderly (>65 years) patients (waiting time 730 vs 1357 days nationally; P<0.001), who 
received predominantly DCD kidneys from old donors (mean donor age 64), whereas 
younger recipients received equal proportions of living-donor, DBD and DCD kidney 
transplants. Death-censored kidney graft survival was nevertheless comparable for young 
and elderly recipients, although transplantation conferred a survival benefit from listing for 
only younger recipients. Local expansion in DCD kidney transplant activity therefore 
improves survival outcomes for younger patients and addresses inequity of access to 
transplantation for elderly recipients. 
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Introduction 
The number of kidney transplants from donation after circulatory death (DCD) donors has 
risen rapidly in the UK over the last ten years (1). From a baseline of approximately 100 
transplants per annum prior to 2003/04, over 800 DCD kidney transplants were performed 
in 2013/14, with DCD transplantation now representing approximately 40% of all deceased-
donor renal transplant activity in the UK. Worldwide, only the Netherlands achieves similar 
DCD donor rates per million population (1). 
Several aspects of this expansion merit consideration. Firstly, it has been accomplished 
through acceptance of increasingly elderly donors: in 2003/04 the mean age of DCD kidney 
donors nationally was 43, whereas in 2013/14 this was 54; significantly greater than the 
contemporaneous donation after brain death (DBD) cohort (mean age 49, P<0.0001). 
Consequently, almost half the DCD kidneys currently transplanted in the UK fulfil criteria for 
expanded donors (ECD) on the basis of donor age greater than 60. Secondly, the expansion 
in DCD kidney transplantation in the UK has not occurred uniformly, and marked regional 
differences persist in DCD donation rates (2). This is important, because unlike DBD kidneys, 
DCD kidneys were, until September 2014 (3), not allocated nationally; instead both kidneys 
were offered to the local renal transplant centre. Consequently, DCD kidney transplant 
activity in the different UK renal transplant centres varies widely; representing less than 
10% of deceased donor transplant activity in some centres and greater than 60% in others 
(4). 
Following the introduction of a programme to expand DCD kidney transplantation (5-7), the 
Cambridge Transplant Centre now performs approximately twice as many DCD as DBD 
kidney transplants. Studies to date have generally focused on comparing outcomes of DCD 
and DBD kidneys from transplantation (5-14). However, given the difference in allocation 
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policy for DCD and DBD kidneys, in which utilisation of a local DCD resource will impact 
upon access to the national DBD pool, we sought to examine how an alteration in the 
balance of deceased kidney transplants impacted on outcomes from listing, with particular 
consideration whether any distinct waiting list cohort has been more or less advantaged. 
Because variation in patterns of DCD kidney transplantation across UK transplant centres 
persists, this further enabled the analysis of outcomes from listing for Cambridge patients to 
be compared to those achieved in units in which DCD kidney transplant activity had not 
increased as dramatically. In the absence of a prospective trial, such comparison provides a 
means of validating that observed differences were related to different DCD kidney 
transplant practices.  
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Materials and Methods 
Study population and design 
The study population comprised all adult patients (≥ 16 years, n=1459) listed for deceased 
renal transplantation at our centre from 1
st
 August 2002 to 31
st
 July 2012. Recipients were 
categorised according to age at listing: <45 years old; 45 to 65 years old; and ≥65-years-old, 
with the following exclusion criteria: multiple organ transplantation (n=36); transfer to our 
centre whilst on the waiting list (n=10); transfer away from our centre whilst on the waiting 
list (n=22); and travel overseas for transplantation (n=10). During this period, a further eight 
patients received living donor kidney transplants but were never listed for deceased donor 
transplantation and were therefore not included in the analysis. National data (with data for 
the Cambridge Transplant Centre omitted) was obtained from the UK transplant registry 
database held by NHS Blood and Transplant (NHSBT) only, whereas data for the Cambridge 
Transplant Centre was amalgamated from case notes, a prospectively maintained local 
database, and the NHSBT database.  
Study end-points were defined as patient death, cease of engagement with local centre 
(including transferring out of area), or formal study completion (31
st
 July 2012), with the 
primary outcome the fate of listed patients: progression to transplantation; removal from 
waiting list without transplantation; suspension from waiting list (generally due to illness 
from which recovery is anticipated); remaining actively listed; and death. Patients listed or 
transplanted from 2009 onwards were assumed to have correct follow-up entered on the 
local and NHSBT databases; cases prior to 2009 were reviewed individually to identify 
follow-up dates. All-cause graft survival was defined as the time of transplant to time of 
return to renal replacement therapy or death. Patient survival was defined as time from 
listing to death. For the purposes of outcome from listing, patients re-listed after a 
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previously failed transplant, even if previously included, were considered as a new listing 
(n=207). In order to demonstrate how deceased donors used in Cambridge compared with 
those used elsewhere in the UK, data was obtained from NHSBT for all deceased donors 
transplanted into adult recipients (age over 18) in Cambridge and the rest of the UK 
between 2002 and 2012. Donor age, type (DCD vs DBD) and criteria (standard vs expanded) 
were analysed according to financial year (1
st
 April to 31
st
 March).  
All DCD kidneys were procured from controlled, Maastricht category 3/4 (15) donors who 
incurred irrecoverable brain injury, but did not meet the criteria for diagnosis of brainstem 
death. DCD organ procurement for our centre has been detailed previously (5-7, 16, 17), 
and differs from standard US practice in that organ donation was pursued for a minimum of 
four hours after withdrawal of life-supporting treatment, irrespective of the agonal phase 
characteristics (6). Expanded criteria donors (ECD) were defined as those ≥60 years or those 
aged 50-59 years with two of the following three features: hypertension; terminal serum 
creatinine >132 mmol/L; or death from cerebrovascular accident (18). Donors with acute 
kidney injury (high terminal creatinine) were considered for kidney donation only when 
recent tests indicated satisfactory baseline renal function; 49 patients received kidneys from 
donors with terminal creatinine >200 mmol/L (range 200 – 504 mmol/L).  
Organ allocation 
Kidneys from DBD donors were allocated according to the national algorithm as outlined by 
NHSBT (the Deceased Donor Kidney Allocation Scheme (3)): firstly, paediatric patients were 
favoured over adult patients; then 000 HLA-mismatched kidneys were prioritised (with 
preference to highly-sensitised or HLA-homozygous individuals). Beyond this, allocation was 
based on a points system, according to an algorithm incorporating: waiting time; HLA 
match; age; age difference; geographical location; blood group; and HLA type. Although the 
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allocation algorithm was altered in 2006, the same algorithm applied to all patients on the 
waiting list at any one time and there was no difference in the age-related components of 
the algorithms. During the study period, DCD kidneys were not allocated nationally, but DCD 
kidneys were offered on a regional basis (20 regions in the UK) to the local transplant centre 
that covered that region. The centres were at liberty to select recipients felt most suitable 
for these kidneys, and no formal arrangement existed for sharing with other regional 
centres. At the Cambridge Transplant Centre, a similar algorithm to that used nationally for 
DBD kidneys was used to select recipients for DCD kidneys, but with the ability to limit the 
algorithm to select only elderly recipients (typically over 60 years old) for kidneys deemed 
more ‘marginal’ at the discretion of the on-call team. As described previously (5, 7), pre-
implantation biopsy analysis was used routinely to help determine the suitability of elderly 
deceased-donor kidneys for transplantation. Living donor transplants were arranged 
according to standard UK practice. 
Data and statistical analysis 
Data obtained for each patient included: date of birth, sex, date of end-stage renal failure 
(ESRF) diagnosis, date of pre-emptive listing, date of graft failure if previously transplanted, 
cause of ESRF, previous transplantation, date of listing, date of transplantation, date of 
death, cause of death, date of removal from list, date of suspension from list, date of graft 
loss, cause of graft loss, donor age, donor type (whether DBD, DCD, or living). Graft and 
patient survival were calculated using Kaplan-Meier estimates and log-rank tests for 
statistical significance. In the comparison of patient survival from listing (Figure 6c), only 
survival from the time of listing for the first transplant was analysed. For the elderly cohort, 
comparison of survival for those transplanted against those remaining on the waiting list 
was also assessed by the time-dependent non-proportional Cox regression model (19), 
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adjusting for primary disease, ethnicity, gender, blood group, BMI, and sensitisation status. 
Median waiting times for deceased donor-kidney transplantation were calculated using 
Kaplan-Meier method of estimation, by excluding patients that were transplanted using a 
kidney from a living donor, and censoring for removals (ill-health or recovery of renal 
function) or deaths on the list. Rates of de-listing for transplantation (death or removal from 
the list without transplantation) were also estimated by Kaplan-Meier analysis, by censoring 
for transplantation. The Kidney Donor Profile Index (KDPI) was calculated using the 2014 
reference dataset (20). Categorical data were examined with the Chi-squared test, non-
parametric continuous data were assessed using Kruskal-Wallis test and parametric 
continuous data with Student’s t test. Statistical analysis was performed using SAS (v9.1; SAS 
Institute, Cary NC, USA), and GraphPad Prism (v 5.03; GraphPad Software Inc, CA, US.). 
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Results 
Changing profile of deceased kidney transplants 
A single-centre, retrospective observational cohort study was performed to examine 
outcomes for all adult patients listed for kidney transplantation at the Cambridge Transplant 
Centre between 2002/03 and 2011/12. As reference, during this period the number of DCD 
adult kidney only transplants performed increased markedly; from 11 in the 2002/03 
financial year to 68 in the 2011/12 financial year (Figure 1A), which represents a much 
higher proportion of deceased donor kidney transplantation than occurred nationally 
(Figure 1B). Figure 1A also shows that numbers of living donor kidney transplants increased 
over the study period, but to a lesser extent, whilst numbers of DBD kidney transplants 
remained relatively static. In keeping with national trends, the age of the DCD kidney donors 
increased throughout the study period (Figure 1C. Consequently, compared to the DBD 
kidney transplants, a significantly higher proportion of the DCD kidney transplants 
performed were from ECD donors (DBD; 33% (114 of 346) vs. DCD; 44% (186 of 426), χ
2
 
P=0.003).  
Elderly listed patients are less likely to receive a kidney transplant 
To assess how the expansion in availability of predominantly elderly DCD kidneys impacted 
upon the recipient pool, outcomes from listing for study patients were compared according 
to three listed-patient groups: younger than 45 years old; from 45 to 65 years old; and older 
than 65 years at listing for kidney transplantation (Table 1). Transplant outcomes and donor 
details are listed in Table 2. Over the entire study period, elderly listed patients were less 
likely to be transplanted, and more likely to be removed from the waiting list, than younger 
patients (Table 2). Nevertheless, comparison of outcomes from listing at 1, 3 and 5 years 
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with national data (Figure 2) demonstrated that for all age groups, patients on the 
Cambridge waiting list were more likely to be transplanted than their equivalent UK cohort. 
This difference was more marked for the elderly: whereas 59% of Cambridge-listed patients 
over 65 years old were transplanted by five years, only 38% of the equivalent national 
waiting-pool had received a kidney transplant (P<0.001; Chi-Squared test). Conversely, a 
greater proportion of elderly listed patients nationally were either removed from the list or 
died before transplantation (at five years: Cambridge 41% vs National 46%; P<0.001).  
Higher rates of delisting for elderly waiting list patients 
Comparison of the rate of removal of patients from the waiting-list due to death or ill-health 
was further assessed by Kaplan-Meier analysis of outcomes for the Cambridge listed 
patients (Figure 3). This confirms that rates of delisting were significantly higher for the 
cohort of elderly listed patients, with less than 50% of patients over 65 years old who were 
listed, but not transplanted, still active on the list after four years. Analysis of the UK dataset 
also revealed that the rate of removal from the waiting list was significantly higher for the 
elderly cohort, but that for each age range, delisting rates were similar to those observed in 
Cambridge (Figure 3), suggesting that the smaller proportion of elderly patients dying or 
being removed from the waiting list in the Cambridge Transplant Centre does not reflect a 
bias to listing relatively fitter recipients.  
Donor profiles differ markedly according to recipient age 
In considering why elderly listed patients in Cambridge have greater access to 
transplantation, analysis of the type of kidneys transplanted into each recipient age group 
reveals marked differences (Table 2). Whereas the proportions of living-donor, DCD and 
DBD kidney transplants were broadly equivalent for listed recipients under 45 years old, 
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patients over 65 received kidney transplants from predominantly DCD donors, with DBD and 
living donors together constituting only approximately one-third of the transplants 
performed. Numerically, most DCD kidneys were nevertheless transplanted into recipients 
in the younger age groups (Table 2). 
In keeping with the older age of DCD kidney donors, elderly patients generally received 
kidney transplants from more elderly donors (Figure 4, Table 2). Calculation of the KDPI 
donor score revealed that these kidneys could be considered extremely marginal (Table 2), 
with 69% of kidneys transplanted into the elderly cohort scoring greater than 85.  
The relatively rapid rate of removal of elderly patients from the waiting list due to death or 
illness suggests that local availability of DCD kidneys may be a particularly important factor 
underlying the difference in Cambridge and National transplantation rates for elderly 
recipients. In support, comparison of Cambridge and National waiting times for kidney 
transplantation (Figure 5) highlights that waiting times for the three recipient age groups 
were comparable for Cambridge patients, but that elderly patients waited substantially 
longer nationally. Moreover, waiting times for our elderly patients fell during the study 
period (Figure 5); presumably reflecting the continued expansion of the DCD kidney 
transplant program. Although the simultaneous increase in living donor transplant activity in 
our centre (Figure 1a) would be expected to contribute to a fall in waiting times, the impact 
is likely to be less pronounced than for the DCD kidney transplant program, because 
substantially fewer living donor kidney transplants were performed at our centre during the 
study period than DCD kidney transplants (283 vs 426; including 8 living donor recipients 
never listed for a deceased donor transplant (Figure 1a)). It should also be noted that, 
compared to the UK, our living donor program has remained relatively small during the 
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study period (283 of 1088 (26%) kidney transplants performed in Cambridge vs. 7976 of 
22163 (36%; P<0.0001) performed nationally). Similarly, the fall in the Cambridge waiting 
times was most apparent for the 45-65 and >65 recipient age groups (Figure 5) and in both 
cohorts, DCD transplant activity was dominant (Table 2).    
The reason that elderly UK patients are apparently disadvantaged in their access to DBD 
kidney transplantation is not immediately obvious, but we thought it likely a facet of the 
algorithm for national sharing of DBD kidneys (21), whereby younger recipients of DBD 
kidneys generally score more highly than elderly. Consequently, elderly recipients must wait 
longer to accrue sufficient waiting-time points on the algorithm to outcompete younger 
recipients (Figure 5 and Table 3). Although DCD kidneys were not allocated nationally during 
the study period, application of the algorithm to our recipients revealed that for all age 
groups, the allocation score was less for Cambridge DCD recipients than for nationally 
allocated DBD kidneys (Table 3). This is partly due to the smaller local recipient pool that 
generally prevents close HLA-matching between donor and recipient, but mostly reflects the 
much shorter waiting times for transplantation.  
Kidney transplant outcome and patient survival from listing  
Outcomes for DCD kidney transplantation in our unit have been described previously (5-7) 
and report similar outcomes for DCD and DBD kidney transplantation. All-cause kidney graft 
survival was poorer for elderly recipients (Figure 6a), but largely reflects that 12 of 18 graft 
losses in this group were due to recipient death (generally due to malignancy or sepsis) with 
a functioning graft (median pre-terminal creatinine 151 μmol/l). Graft survival when 
censored for recipient death was comparable for the three recipient groups (Figure 6b). In 
anticipation that the impact of increased kidney transplant activity would be most apparent 
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in an assessment of recipient outcomes that included time on the waiting list, recipient 
survival for each age group was assessed from the point of listing and compared to those 
listed patients who did not receive a transplant (Figure 6c). This analysis confirms that 
transplantation was associated with improved survival for patients in the two younger age 
groups, but not for the elderly cohort. An additional non-proportional Cox regression model 
analysis (19) was performed to compare survival for the elderly cohort who received a 
transplant against those who remained on the waiting list. This also failed to show a survival 
advantage for transplantation in the elderly (Hazard ratio = 1.87 (95% CI 0.42-8.26); P = 0.4).  
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Discussion 
The rate of expansion of DCD kidney transplantation in the UK has been remarkable. 
However marked variations in regional Intensive Care Unit DCD donation rates (2), allied to 
apparent differences between transplant centres in the assessment of suitability of DCD 
kidneys for transplantation, has resulted in geographical fragmentation of current DCD 
kidney transplant activity. The major consequence of this piecemeal implementation is that 
transplanting increasing numbers of locally-resourced DCD kidneys will, for a particular 
centre, likely restrict access of that centre’s listed population to the nationally-allocated 
DBD kidney pool; one of the major factors determining national allocation is waiting-time 
for a transplant. The impact of this apparent conflict between local DCD kidney and national 
DBD kidney allocation would be potentially more marked if, as was once generally 
considered, DCD kidneys were of inherently poorer quality than DBD kidneys, but analyses 
of individual centre (5, 7) and National UK transplant data (8, 9) have demonstrated that 
age-matched outcomes for DCD and DBD kidney transplantation are similar. Nevertheless, 
increased use of a local circulatory death donor pool would potentially result in 
transplantation of less well-matched kidneys from older donors than the recipients would 
have otherwise received from the national DBD pool. Hence we felt it important to analyse 
how the marked expansion in DCD kidney transplantation in our centre has affected 
recipient outcomes, but to focus this analysis on outcomes from listing for various age 
groups of the waiting list population. Our analysis suggests waiting times for transplantation 
are improved for all recipients, and given the equivalent outcomes from transplantation for 
DCD and DBD kidneys in our centre (5-7), that this is associated with improved survival 
outcomes from listing in recipients under 65 years old. The situation is more complex for 
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older recipients, because although this group arguably gains most in terms of equity of 
access to transplantation, their survival is not enhanced by transplantation.  
There are potentially several reasons why elderly listed patients are generally disadvantaged 
in their access to transplantation. Our analysis highlights that options for living-donor 
transplantation for our elderly recipients are generally more limited than for younger 
recipients, presumably either because of concerns relating to fitness of the spouse or 
because living donation from offspring to parent is not perceived as acceptable as parent to 
offspring donation. The apparent inequity of access of elderly recipients to the national DBD 
pool is largely due to the UK matching algorithm for DBD kidney allocation (21). The 
algorithm calculates an allocation score for level 1, 2 and 3 HLA-mismatched kidneys based 
on, among other factors: waiting-time for transplantation; the degree of HLA matching; and 
age difference between donor and recipient, but was designed specifically ‘to ensure well-
matched transplants for younger patients while recognizing that HLA matching is less 
important for older patients’. Thus the algorithm is weighted to preferentially allocate more 
closely HLA-matched kidneys to younger recipients, irrespective of donor/recipient age 
difference. Accordingly, younger recipients receive an exponentially greater number of 
points than elderly recipients for receipt of a well-matched kidney, and a crude analysis of 
the algorithm suggests that the elderly cohort would need to accrue approximately four 
years’ waiting-time points to compensate for this bias to younger recipients. This carries the 
major drawback that, as highlighted by our analysis, the window for transplantation of 
elderly listed recipients is small and that approximately half of these patients will either 
have died or become too frail to transplant by four years. This presumably explains why, 
when compared to younger listed recipients, only approximately half as many elderly listed 
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patients nationally receive a transplant, and yet at five years the percentage of patients still 
waiting for transplantation is similar for both groups (~15%, see Figure 2). 
We ostensibly adopted the same algorithm as used nationally for allocating local DCD 
kidneys to our recipients, and it is perhaps surprising that this enabled us to transplant our 
elderly recipients. Our elderly recipients generally received kidneys from elderly DCD donors 
(Table 2) and we think this is partly a consequence of a relative reduction, when compared 
to the national DBD pool, in the size of the local DCD donor pool that limits availability of 
well-matched younger recipients for a proportion of the elderly DCD donors. However, local 
allocation of DCD kidneys provided the flexibility to impose additional restrictions on 
recipient selection. We have also, at the clinicians’ discretion, deliberately chosen to 
allocate kidneys from elderly DCD donors that were deemed more ‘marginal’ to only elderly 
recipients, and it is notable that a substantially higher proportion of the DCD than DBD 
kidneys transplanted fulfilled ECD status. This mirrors the strategy adopted by the 
Eurotransplant Senior Program (22), in which kidneys from elderly donors are preferentially 
transplanted into elderly recipients. Our analysis provides further support for the benefits of 
this approach. The kidneys transplanted into our elderly recipients (mainly from elderly DCD 
donors) could be considered extremely marginal, with 69% having a KDPI score greater than 
85, and yet graft outcomes were generally favourable and prejudiced mainly by recipient 
death with a functioning graft. The surprisingly good outcomes for these kidneys may reflect 
our routine use of pre-implantation biopsy analysis to help determine suitability for 
transplantation (5, 7).  
Irrespective, it is clear that the availability of locally-allocated DCD kidneys has enabled us to 
transplant a far greater proportion of our transplant waiting list than would otherwise be 
Page 16 of 35
amjtransplant@duke.edu
American Journal of Transplantation
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
CONFIDENTIAL
 17
the case. The short waiting time for transplantation achieved, currently the lowest in the UK 
(23), has substantially improved the opportunity for transplanting our elderly listed 
recipients. As the haemodialysis population ages (24), it is likely that greater numbers of 
elderly patients will continue to be listed for kidney transplantation; their deliberate 
selection as recipients of elderly DCD kidneys may provide an opportunity for 
transplantation not otherwise afforded. In this regard, our findings are likely to have 
relevance beyond UK transplant practice. Death on the waiting list appears to be an even 
greater problem for elderly patients in the United States (25), and yet the recent 
introduction of the US Kidney Allocation System has been associated with increased discard 
rates of kidneys with highest KDPI scores (26), and has seen a fall in transplant rates for 
elderly listed patients and an increase in their waiting time for transplant (27). Given that 
kidneys with high KDPI are typically from ECD circulatory death donors, and that such 
kidneys are allocated locally rather than nationally, our findings suggest that their 
preferential allocation to elderly listed patients may provide an opportunity for 
transplantation for these recipients not otherwise available.   
One concern raised by our analysis is whether it is appropriate, in the absence of a 
demonstrable survival benefit for transplantation, to continue to allocate organs to elderly 
recipients that may otherwise improve survival of younger recipients. The apparent lack of 
survival benefit for transplantation in our elderly cohort is surprising, because previous 
analyses from the UK have suggested otherwise (28, 29), but does not appear to relate to 
the limited number of elderly patients in our study; in contrast to the younger cohorts, the 
survival curves for the elderly transplanted and the elderly that remained on dialysis are 
closely matched (Figure 6C). This may relate to continuing improvements in survival for 
elderly patients with end-stage renal failure on haemodialysis (24). Nevertheless, we feel it 
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justifiable to continue to list elderly recipients on the basis of patient choice and 
improvement in quality of life (30, 31). In addition, even allowing for deliberate selection of 
elderly recipients for kidneys deemed more marginal, proportionally fewer of the elderly 
than younger listed patients ultimately received a kidney transplant (Table 2), and it is 
therefore difficult to argue that the elderly have been unfairly advantaged by our selection 
policy. Moreover, those patients over 65 years old listed during the study period represent 
less than 10% of all listed patients, and it should be stressed that the majority (89%) of DCD 
kidneys in our study were transplanted into patients under 65 years old at time of listing. 
Hence, although the Cambridge DCD program appears to perhaps have made the biggest 
difference to outcomes for elderly listed patients, the greatest impact has instead been on 
younger listed patients, with the many more transplants realised by the program conferring 
improved survival from listing.  
In summary, our analysis demonstrates that local expansion in DCD transplant activity can 
improve outcomes for young and elderly listed patients. For elderly listed recipients, an 
awareness that their window for transplantation is likely to be narrow may justify increased 
use of ‘marginal’ kidneys with high KDPI scores.  
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Figure Legends 
Figure 1: Changing profiles of deceased kidney donors  
(A) Numbers of expanded criteria donor (ECD) and standard criteria donor (SCD) kidneys 
transplanted at the Cambridge Transplant Centre according to deceased donor type 
(donation after brain death (DBD) and donation after circulatory death (DCD)). Numbers of 
living donor transplants (LD) are included for comparison. (B) DCD kidney transplants, as a 
percentage of deceased donor kidney transplants in Cambridge and the UK (C) Regression 
lines of donor age superimposed on graphs depicting median and interquartile range of 
donor age per year for Cambridge DBD and DCD donors: P=0.047, analysis of covariance. 
Year denotes financial year. 
 
Figure 2: Comparison of outcomes for wait-listed patients nationally and at the Cambridge 
Transplant Centre 
Waiting list status at one, three and five years from listing of patients listed for renal 
transplantation between 2002 and 2008 nationally and locally (at the Cambridge Transplant 
Centre) according to age at listing: n= 7118, 8620, 1837 for national and 375, 459 and 59 for 
local patients listed aged under 45, 45 to 65, and over 65 years, respectively. *P<0.05; 
**P<0.001; Fisher’s Exact Test.  
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Figure 3: Rates of delisting from kidney transplant waiting list  
Kaplan-Meier analysis of rates of delisting (due to death or removal from the waiting list and 
censored for transplantation) for patients listed at the Cambridge Transplant Centre (dotted 
line) and in the rest of the UK (solid line), according to age at listing for transplantation. Log-
rank analysis confirms that at the Cambridge Transplant Centre, elderly (>65 years) patients 
were delisted significantly more rapidly than younger patients (P < 0.01), but that for any 
age cohort, local (Cambridge) rates of delisting were not different from UK rates (P = NS).  
 
Figure 4: Differences in donor profiles according to recipient age at listing 
Scatterplot depicting deceased donor age for each recipient group (Kruskal-Wallis 
P<0.0001). 
 
Figure 5. National and Cambridge waiting times according to recipient age 
Waiting time to adult kidney transplantation in the UK and Cambridge according to age at 
listing and year of listing. Graph shows median +/- confidence intervals and P values depict 
log-rank analysis.   
 
  
Page 21 of 35
amjtransplant@duke.edu
American Journal of Transplantation
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
CONFIDENTIAL
 22
Figure 6. Kidney graft and patient survival.  
Kaplan-Meier curves and numbers at risk for (A) all-cause graft survival (P=0.0004; Log-Rank 
test) and (B) graft survival censored for death as a cause of graft loss according to age at 
listing (P=0.2705). (C) Kaplan-Meier curves and numbers at risk for patient survival from first 
listing in transplanted (black line) and non-transplanted patients (grey line) for those aged: 
under 45 (left); 45 to 65 (middle); and over 65 (right); at time of listing. 
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Table 1 
 Age at listing P-value 
 Under 45 45 to 65 Over 65  
Number of patients 
listed 
557 688 136  
Age at listing (Median, 
range) 
36.2 (16.2-45.0) 55.0 (45.0-65.0) 67.9 (65.1-75.5)  
Median length of 
follow-up in days* 
(range) 
1519 (0-3624) 1271 (0-3648) 1164 (26-3592)  
Sex
+ 
Male 
Female 
 
343 (62%) 
214 (38%) 
 
445 (65%) 
243 (35%) 
 
89 (65%) 
47 (35%) 
P=0.47 
Cause of ESRF
+ 
Cystic kidney disease 
Diabetes mellitus 
Glomerulonephritis 
IgA nephropathy 
Pyelointerstitial 
Nephritis 
Systemic 
Other 
 
64 (11.5%) 
38 (6.8%) 
42 (7.5%) 
68 (12.2%) 
90 (16.2%) 
27 (4.9%) 
228 (40.9%) 
 
162 (23.6%) 
73 (10.6%) 
66 (9.6%) 
53 (7.7%) 
40 (5.8%) 
47 (6.8%) 
247 (35.9%) 
 
15 (11.0%) 
11 (8.1%) 
14 (10.3%) 
11 (8.1%) 
8 (5.9%) 
10 (7.4%) 
67 (49.3%) 
P<0.0001 
Pre-emptively listed
+ 
83 (15%) 53 (7.7%) 
(1 unknown) 
5 (3.7%) P<0.0001 
Previous transplant
+ 
117 (21%) 85 (12%) 5 (3.7%) P<0.0001 
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Table 2 
 Age at listing P value 
 Under 45 45 to 65 Over 65  
Number listed 557 688 136  
Outcomes
+ 
Transplanted 
Suspended 
Removed or died 
Remained active 
 
411 (73.8%) 
42 (7.5%) 
20 (3.6%) 
84 (15.1%) 
 
479 (69.6%) 
115 (16.7%) 
14 (2.0%) 
80 (11.6%) 
 
72 (52.9%) 
9 (6.6%) 
30 (22.1%) 
25 (18.4%) 
P<0.0001  
Age at transplantation 
(Median, range) 
37 (17-49) 57 (45-70) 69 (66-75)  
Donor age
** 
(Median, range) 
44 (1-70) 56 (2-82) 67 (23-79) P<0.0001 
xx
 
Donor type (%)
+ 
DBD 
DCD 
Live donor 
 
127 (31%) 
130 (32%) 
154 (37%) 
 
119 (25%) 
243 (51%) 
117 (24%) 
 
17 (24%) 
45 (63%) 
10 (14%) 
P<0.0001  
*KDPI
** 
(Median, range) 
46 (1-100) 77 (1-100) 94 (18-100) P<0.0001 
xx
 
Graft failure  
(% of transplanted) 
All cause 
Censored for death 
 
 
49 (11.9%) 
42 (10.2%) 
 
 
60 (12.5%) 
45 (9.4%) 
 
 
18 (25%) 
6 (8.3%) 
 
Death (% of listed) 
With transplant 
Without transplant 
40 (7.2%) 
13 (2.3%) 
27 (4.8%) 
59 (8.6%) 
20 (2.9%) 
39 (5.7%) 
26 (19%) 
15 (11%) 
11 (8.1%) 
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Table 3 
 
 
 
Age at 
listing 
National DBD Kidney Transplants Local DCD Kidney Transplants  
Number of 
transplants 
Median KAS (IQ Range) Number of 
transplants 
Median KAS (IQ Range) P-value 
Under 45 2593 3201 (2709 – 3757) 107 2178 (1563 – 2609) <0.0001 
45 to 65 3274 2771 (2156 – 3332) 200 1582 (1300.3 – 2002) <0.0001 
Over 65 654 2327 (1622 – 2909) 33 1385 (1044.5 – 1603) <0.0001 
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